Thalidomide neurotoxicity
- 22 June 2004
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 62 (12) , 2288-2290
- https://doi.org/10.1212/01.wnl.0000130499.91775.2c
Abstract
The authors prospectively followed 14 patients treated with thalidomide for cutaneous lupus erythematosus (CLE), in order to evaluate the occurrence of peripheral neuropathy (PN) and to assess whether PN correlates with thalidomide dose. The patients were followed for up to 24 months with neurologic and electrophysiologic evaluations. Seven patients (50%) developed sensory axonal PN. The median time free from PN was 14 months. PN occurred after 10 months in the majority of patients. No correlations were found between thalidomide cumulative dose and occurrence of PN (Mann-Whitney U test; p > 0.16).Keywords
This publication has 9 references indexed in Scilit:
- Thalidomide-induced neuropathy: A ganglionopathy?Neurology, 2003
- Low-Dose Thalidomide Therapy for Refractory Cutaneous Lesions of LupusErythematosusArchives of Dermatology, 2003
- Thalidomide-induced neuropathyNeurology, 2002
- Incidence and Risk Factors for Thalidomide Neuropathy: a Prospective Study of 135 Dermatologic PatientsJournal of Investigative Dermatology, 2002
- Update on therapy — thalidomide in the treatment of lupusLupus, 2001
- p75-Mediated NF-κB Activation Enhances the Survival Response of Developing Sensory Neurons to Nerve Growth FactorMolecular and Cellular Neuroscience, 1999
- Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy.Annals of the Rheumatic Diseases, 1994
- Detection, characterization, and staging of polyneuropathy: Assessed in diabeticsMuscle & Nerve, 1988
- Thalidomide neuropathy: a clinical electrophysiological, and histological follow-up study.Journal of Neurology, Neurosurgery & Psychiatry, 1968